These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35163161)

  • 41. Subtype-WGME enables whole-genome-wide multi-omics cancer subtyping.
    Yang H; Zhao L; Li D; An C; Fang X; Chen Y; Liu J; Xiao T; Wang Z
    Cell Rep Methods; 2024 Jun; 4(6):100781. PubMed ID: 38761803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
    Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
    PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternity Log study: a longitudinal lifelog monitoring and multiomics analysis for the early prediction of complicated pregnancy.
    Sugawara J; Ochi D; Yamashita R; Yamauchi T; Saigusa D; Wagata M; Obara T; Ishikuro M; Tsunemoto Y; Harada Y; Shibata T; Mimori T; Kawashima J; Katsuoka F; Igarashi-Takai T; Ogishima S; Metoki H; Hashizume H; Fuse N; Minegishi N; Koshiba S; Tanabe O; Kuriyama S; Kinoshita K; Kure S; Yaegashi N; Yamamoto M; Hiyama S; Nagasaki M
    BMJ Open; 2019 Feb; 9(2):e025939. PubMed ID: 30782942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Directional integration and pathway enrichment analysis for multi-omics data.
    Slobodyanyuk M; Bahcheli AT; Klein ZP; Bayati M; Strug LJ; Reimand J
    Nat Commun; 2024 Jul; 15(1):5690. PubMed ID: 38971800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiomics Substrates of Resistance to Emerging Pathogens? Transcriptome and Proteome Profile of a Vancomycin-Resistant
    Pinto L; Torres C; Gil C; Santos HM; Capelo JL; Borges V; Gomes JP; Silva C; Vieira L; Poeta P; Igrejas G
    OMICS; 2020 Feb; 24(2):81-95. PubMed ID: 32073998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunomodulatory Factors in Primary Endometrial Cell Cultures Isolated from Cancer and Noncancerous Human Tissue-Focus on RAGE and IDO1.
    Tkaczuk-Włach J; Kędzierski W; Jonik I; Sadok I; Filip A; Kankofer M; Polkowski W; Ziółkowski P; Gamian A; Staniszewska M
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
    Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
    J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation and association analyses in microbiome study integrating multiomics in health and disease.
    Xia Y
    Prog Mol Biol Transl Sci; 2020; 171():309-491. PubMed ID: 32475527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation.
    Zhou Q; Eldakhakhny S; Conforti F; Crosbie EJ; Melino G; Sayan BS
    Cell Death Dis; 2018 May; 9(5):504. PubMed ID: 29724995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer.
    Bisht V; Nash K; Xu Y; Agarwal P; Bosch S; Gkoutos GV; Acharjee A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
    Guo S; Yang J; Wu M; Xiao G
    Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
    Kato M; Onoyama I; Yoshida S; Cui L; Kawamura K; Kodama K; Hori E; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
    Int J Cancer; 2020 Oct; 147(7):1987-1999. PubMed ID: 32159851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker.
    Kim JW; Song JY; Lee JM; Lee JK; Lee NW; Yeom BW; Lee KW
    Int J Gynecol Cancer; 2008; 18(6):1352-9. PubMed ID: 18217976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.
    Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
    J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of NRP-1 and NRP-2 in Endometrial Cancer.
    Oplawski M; Dziobek K; Grabarek B; Zmarzły N; Dąbruś D; Januszyk P; Brus R; Tomala B; Boroń D
    Curr Pharm Biotechnol; 2019; 20(3):254-260. PubMed ID: 30806307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.